CLIOSS adopts Veeva Vault solutions for trial management

6th February 2019 (Last Updated February 6th, 2019 13:00)

Clinical Organization for Strategies & Solutions (CLIOSS), an Italian clinical trial services provider, has partnered with Spain-based Veeva Systems to optimise trial management for sponsors.

CLIOSS implemented Veeva Vault eTMF and Veeva Vault CTMS solutions in order to improve trial efficiency as well as provide sponsors better visibility into trial activities.

Vault eTMF is designed to offer an active TMF operating model that can manage all processes and documents in a single system in real-time.

Meanwhile, Vault CTMS allows study teams and partners to gain better insights into the trial lifecycle for improving decision-making and study quality.

The clinical applications can be used collectively to share trial documents with cross-functional teams and sponsors in real-time.

CLIOSS managing director Cristina Davite said: “We needed a modern system that could manage our increasingly complex trial activities.

“Veeva Vault allows us to work more efficiently with sponsors and deliver high-quality studies more quickly. Now we have a clinical solution that will help us succeed on a global scale.”

The contract research organisation (CRO) is expanding its operations into Chinese clinical research market.

Through the new partnership, CLIOSS intends to eliminate manual, paper-based processes in order to refine its collaboration with sponsors across China and Europe.

Veeva Systems Europe development cloud strategy vice-president Rik Van Mol said: “CROs are leading a major industrywide shift to unify clinical operations for improved study execution.

“Veeva Vault gives CLIOSS modern clinical applications to simplify collaboration with sponsors and drive greater efficiency across its trials.”

In addition to Veeva Vault eTMF and Vault CTMS, the company’s Vault Clinical Operations Suite consists of Veeva Vault Study Startup that speeds up collection, tracking and management of study start-up activities and content.